Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer and Allogene enter asset contribution agreement for Pfizer's CAR T portfolio

April 4, 2018

Eisai submits sNDA for pediatric use of Fycompa

April 4, 2018

ThromboGenics reports phase I/II topline data on THR-317 for DME

April 4, 2018

SpinalCyte reports data from phase I/II trial of CybroCell

April 4, 2018

Personal Genome Diagnostics, Five Prime Therapeutics to develop bemarituzumab companion diagnostic

April 4, 2018

GenSight reports topline results from REVERSE trial of GS-010 in LHON

April 4, 2018

EMA validates MAA for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer

April 4, 2018

Patient recruitment ongoing in phase I/II trial of ST-400

April 4, 2018

European Commission grants orphan drug designation to Altemia for sickle cell disease

April 4, 2018

Topline results from phase II study of fostamatinib in IgA nephropathy

April 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...